BIOFLOXCIN Film Coated Tablet 750 Milligram
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
19-04-2024
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
CIPROFLOXACIN HYDROCHLORIDE
Inapatikana kutoka:
Niche Generics Limited
Kipimo:
750 Milligram
Dawa fomu:
Film Coated Tablet
Idhini ya tarehe:
2005-10-07
Tabia za bidhaa
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
BioFloxcin 750 mg Film-coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains ciprofloxacin hydrochloride equivalent to 750mg ciprofloxacin.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablet
Oval, white film-coated tablet with a scoreline on both sides.
The tablet can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Ciprofloxacin is a synthetic, 4-quinolone derivative with bactericidal activity against a wide range of Gram-negative
and Gram-positive organisms.
Ciprofloxacin is indicated for the treatment of single infections or mixed infections caused by two or more susceptible
organisms. It may be used for infections caused by organisms resistant to other antibiotics, including aminoglycosides,
penicillins and cephalosporins.
The extensive tissue penetration of ciprofloxacin combined with its enhanced antibacterial activity (including
antipseudomonal activity), enables ciprofloxacin to be used alone (pending sensitivity results) or in combination with
an aminoglycoside or with beta-lactam antibiotics, for instance when severe neutropenia is present, or with an antibiotic
active against anaerobes where the presence of _Bacteroides fragilis _is suspected.
Ciprofloxacin is indicated for the treatment of the following infections caused by sensitive bacteria:
RESPIRATORY TRACT INFECTIONS: e.g. lobar and bronchopneumonia, acute and chronic bronchitis, acute exacerbation of
cystic fibrosis, bronchiectasis, empyema. Ciprofloxacin is not recommended as first line therapy for the treatment of
pneumococcal pneumonia (see Section 4.4, Warnings and Precautions section). In circumstances where a physician
considers it appropriate to use cipro
Soma hati kamili
